The UC Hastings Lecture Series on Bioethics, sponsored by The Lawrence M. Nagin '65 Faculty Enrichment Fund
The UC Hastings Lecture Series on Bioethics, sponsored by The Lawrence M. Nagin '65 Faculty Enrichment Fund is a four-part lecture series featuring nationally acclaimed experts who will discuss cutting-edge issues in bioethics, their legal significance, and their impact on various communities.
Each talk takes place from 12 to 1 p.m. at UC Hastings Law. The lectures are open to the public and free to attend. Sponsored by the Lawrence M. Nagin '65 Faculty Enrichment Fund and co-sponsored by the UCSF Center for Health and Community and the UCSF/UC Hastings Consortium on Law, Science, and Health Policy.
Please see below for the location and lecture details. Questions? Please contact Professor Osagie Obasogie.
UC Hastings Law
200 McAllister, Alumni Reception Center
San Francisco
March 1, 2010 at 12 p.m.
Ethical Issues in Personal Genomics: What's My Beef and Where's the Beef? featuring Dr. Mildred Cho
Join Dr. Mildred Cho, Stanford Medical School professor and associate director of the Stanford Center for Biomedical Ethics, as she discusses Ethical Issues in Personal Genomics: What's My Beef and Where's the Beef?
Personal genomics is often thought to be the first step towards truly individualized medicine, where individuals can receive medical care and information about disease predisposition that is tailored to their unique genetic makeup. Although a burgeoning industry has developed to offer these services - often bypassing health professionals by selling genomic tests directly to consumers - this practice has significant social and ethical implications that raise important questions for law and public policy.
March 15, 2010 at 12 p.m.
The Talking Helix featuring Professor Patricia Williams
Join Professor Patricia Williams of Columbia Law School as she discusses, The Talking Helix.
Author of the critically acclaimed, The Alchemy of Race and Rights, columnist for The Nation, and recipient of the MacArthur Fellowship, Williams has played a prominent role in modern legal thought. In this lecture, she will discuss some of the ethical and legal challenges surrounding the uncritical use of DNA technologies in criminal investigations.
March 29, 2010 at 12 p.m.
An Atypical Suicide? The Clinical Trial as Pharmaceutical Marketing Tool featuring Dr. Carl Elliott
Join Dr. Carl Elliott, a professor in the Center for Bioethics and the Departments of Pediatrics and Philosophy at the University of Minnesota, for the discussion, An Atypical Suicide? The Clinical Trial as Pharmaceutical Marketing Tool.
When a young man committed suicide in an industry-sponsored clinical trial of atypical antipsychotic drugs at the University of Minnesota in 2004, critics charged that he had been coerced into the study. They may be right, but the ethical problem is even larger. Today pharmaceutical companies are designing and analyzing clinical trials not to produce reliable scientific data, but to ensure that their own drugs look superior to the competition. These trials are published in peer-reviewed scientific journals and distributed by drug reps as a way of marketing the drugs. Which raises the question-when is it ethically justified to enroll human subjects in marketing studies?
April 19, 2010 at 12 p.m.
Private Assets, Public Mission: The Moral Landscape of University Technology Transfer featuring Professor David Winickoff
Join Professor David Winickoff, a professor in UC Berkeley's College of Natural Resources, co-director of the Berkeley Science, Technology and Society Center, and a Greenwall Faculty Scholar in Bioethics, for a discussion on Private Assets, Public Mission: The Moral Landscape of University Technology Transfer.
Since the passage of the Bayh-Dole Act in 1980, universities have had the right to own and license, with few restrictions, intellectual property arising from federally funded research. Since then, universities have become not only the locus of knowledge creation, but also agents of its commercialization. Public controversies concerning the management of academic intellectual property have raised serious questions about university commitments to research, teaching and public service. This talk will canvass some of these IP controversies and interpret their implications for the public mission of the modern research university.